Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IL17A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SKIL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GABRA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RGS4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OR5H1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRKG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLDN11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00518 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TNFSF13B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SREK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRGPRF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HOXA-AS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSPAN10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDS5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IZUMO2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on